Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 20, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements...
-
Nov 6, 2014Revenue increased 11 percent to $922 million
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended...
-
Nov 4, 2014-- Reports fourth quarter adjusted diluted earnings per share from continuing operations of $1.68. This represents growth of 13.0 percent on a currency-neutral basis, or 9.1 percent including the unfavorable impact of foreign currency. Reported diluted earnings per share from continuing operations for the fourth quarter were $1.53.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.202 billion for the fourth fiscal quarter ended September 30,...
-
Oct 13, 2014Transaction Advances BD’s Entry into Next Generation Sequencing Market
FRANKLIN LAKES, N.J., October 13, 2014 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a...
-
Oct 5, 2014Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient Safety Solutions
BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to...
-
Sep 23, 2014Point-of-care CD4 analysis system tailored to meet the needs of resource-limited settings
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the World Health Organization (WHO) has issued a...
-
Sep 4, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Morgan Stanley Global Healthcare Conference on Monday,...
-
Aug 8, 2014Sedation Analytics Application Combines Infusion and Ventilator Data to Help Ensure Compliance with Sedation Best Practices for Ventilated Patients
SAN DIEGO, CA, Aug. 8, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the availability of a new capability on the CareFusion Respiratory Knowledge...
-
Aug 7, 2014Fourth quarter revenue of $1.12 billion, up 24 percent; Fiscal 2014 revenue of $3.84 billion, up 8 percent.
SAN DIEGO, Aug. 7, 2014/PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the quarter and fiscal year ended June 30, 2014,...
-
Aug 6, 2014The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection
FRANKLIN LAKES, N.J., August 6, 2014 – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the retail pharmacy...